Modern Diagnostic and Research Centre Limited Clarifies Significant Price Movement to BSE
Modern Diagnostic and Research Centre Limited responded to BSE's inquiry about significant price movement in its securities on April 9, 2026. The company clarified that there is no undisclosed price-sensitive information or pending announcements affecting the stock price. Management attributed the price fluctuations to market conditions and confirmed full compliance with SEBI regulations, assuring continued prompt disclosure of material events.
*this image is generated using AI for illustrative purposes only.
Modern Diagnostic & Research Centre Limited has issued a clarification to BSE Limited regarding significant price movement in its securities, stating that the fluctuations are purely market-driven with no undisclosed information affecting the stock performance.
BSE Inquiry and Company Response
The clarification came in response to BSE's letter bearing reference number L/SURV/ONL/PV/APJ/2026-2027/3542 dated April 8, 2026, which sought explanation for the significant movement in the company's share price across exchanges. The response was submitted on April 9, 2026, by Chairman cum Managing Director Devendra Singh Yadav from the company's Gurgaon office.
Compliance and Disclosure Status
The company emphasized its adherence to regulatory requirements and transparency standards:
| Parameter | Status |
|---|---|
| SEBI (LODR) Regulations Compliance | Fully compliant |
| Material Event Reporting | Promptly disclosed |
| Price-Sensitive Information | None undisclosed |
| Pending Announcements | None requiring disclosure |
Management's Position on Price Movement
The management clarified that the increase in the company's scrip price is entirely due to market conditions and is absolutely market-driven. The company stated that there is no undisclosed price-sensitive information or any impending announcement or corporate action that could influence the stock's price behavior.
Regulatory Assurance
Modern Diagnostic and Research Centre Limited reaffirmed its commitment to maintaining transparency with stock exchanges. The company assured that it will continue to promptly inform exchanges of all material events, information, and actions as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The formal communication was signed by Devendra Singh Yadav, Chairman cum Managing Director (DIN: 01254395), reinforcing the company's position that the management is not connected with any price increase or decrease in the company's securities.
Historical Stock Returns for Modern Diagnostic & Research Centre
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.23% | -6.25% | +17.19% | -21.04% | -21.04% | -21.04% |
What specific market factors or sector trends could be driving the significant price movement in diagnostic industry stocks?
Will SEBI or BSE implement additional monitoring measures for Modern Diagnostic given the unexplained price volatility?
How might this price movement impact Modern Diagnostic's ability to raise capital or pursue strategic acquisitions in the near term?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
